Skip to main content
BRIM logo

BRIM — Investor Relations & Filings

Ticker · 6885 ISIN · TW0006885007 TW Professional, scientific and technical activities
Filings indexed 19 across all filing types
Latest filing 2026-05-12 AGM Information
Country TW Taiwan
Listing TW 6885

BRIM Biotechnology, Inc. specializes in the application of translational science to develop innovative therapies for unmet medical needs. The company utilizes its proprietary Pigment Epithelium-Derived Factor (PEDF) Derived Short Peptide (PDSP) technology platform, which leverages neurotrophic properties to stimulate cell proliferation, wound healing, and tissue regeneration. Its research pipeline primarily targets ophthalmology and degenerative conditions, featuring lead candidates such as BRM421 for dry eye syndrome, BRM424 for neurotrophic keratitis, and BRM521 for osteoarthritis. Operating through an integrated model, the company advances drug candidates to the proof-of-concept stage before pursuing strategic licensing and partnerships for late-stage development. BRIM also incorporates precision medicine and bioinformatics to explore combination therapies and enhance therapeutic outcomes.

Recent filings

Filing Released Lang Actions
115年年報及股東會資料 — 2026_6885_20260612FE5.pdf
AGM Information Classification · 95% confidence The document is titled “Reference Materials for 2026 Annual General Shareholders’ Meeting” and contains detailed proposals, explanations, and attachments to be discussed and voted on at the Annual General Meeting (AGM). It is clearly the set of materials distributed for an AGM and not a standalone financial report, announcement of a report publication, or other regulatory filing. Therefore, it should be classified as AGM Information.
2026-05-12 English
115年年報及股東會資料 — 2026_6885_20260612FE2.pdf
AGM Information Classification · 91% confidence The document is the official Meeting Handbook for the 2026 Annual Shareholders’ (AGM) of Brim Biotechnology, Inc., containing the agenda, meeting procedures, reports (e.g., annual business report, audit committee report), ratification/election proposals, and attachments to be presented and discussed at the physical AGM. It is not the Annual Report itself or a post-meeting voting results notice but rather the materials shared at the AGM.
2026-05-12 English
115年年報及股東會資料 — 2026_6885_20260612FE1.pdf
Proxy Solicitation & Information Statement Classification · 89% confidence The document is a formal notice to shareholders of the upcoming 2026 Annual General Meeting, detailing the meeting agenda, proposals to be voted on, proxy form instructions, voting procedures, and related information. It is not the AGM presentation materials themselves (AGM-R), nor is it the report release or certification, but rather the solicitation of proxies and information statement for the shareholder vote. This matches the Proxy Solicitation & Information Statement category (PSI).
2026-05-12 English
115年年報及股東會資料 — 2026_6885_20260612F02.pdf
AGM Information Classification · 90% confidence The document is titled as the “115年股東常會 議事手冊” and contains the detailed agenda, procedures, and attachments (business report, audit committee report, financial statements, loss compensation table, charter amendments, candidate lists, etc.) prepared for an Annual General Meeting of shareholders. This clearly constitutes the materials shared during an AGM, fitting the definition of AGM Information.
2026-05-12 Chinese
115年年報及股東會資料 — 2026_6885_20260612F01.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a detailed shareholders’ meeting notice (開會通知書) with proxy forms (委託書), attendance procedures, agenda items and solicitation instructions. It is not the AGM presentation itself nor the full annual report; it is proxy solicitation and information materials sent to shareholders to request their votes. Therefore, it matches the Proxy Solicitation & Information Statement category.
2026-05-12 Chinese
115年年報及股東會資料 — 2026_6885_20260612F13.pdf
AGM Information Classification · 92% confidence The document is titled “股東常會各項議案參考資料” and contains the full agenda, proposals, explanatory notes, and attachments for an Annual General Meeting (AGM). It is clearly the set of reference materials presented at the AGM rather than an interim report, earnings release, or proxy certification. Therefore it best fits the AGM Information category.
2026-05-12 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.